Publication | Open Access
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)
28
Citations
21
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1